| scholarly article | Q13442814 |
| P356 | DOI | 10.1161/01.HYP.20.6.737 |
| P698 | PubMed publication ID | 1452289 |
| P2093 | author name string | P Janiak | |
| J F Prost | |||
| J P Vilaine | |||
| A Pillon | |||
| P433 | issue | 6 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 737-745 | |
| P577 | publication date | 1992-12-01 | |
| P1433 | published in | Hypertension | Q5958695 |
| P1476 | title | Role of angiotensin subtype 2 receptor in neointima formation after vascular injury | |
| P478 | volume | 20 |
| Q43542726 | 3-D QSAR studies of triazolinone based balanced AT1/AT2 receptor antagonists. |
| Q28577781 | A role for the angiotensin IV/AT4 system in mediating natriuresis in the rat |
| Q30434317 | ANG II type 2 receptor regulates smooth muscle growth and force generation in late fetal mouse development |
| Q35925706 | AT1 receptor blockade for the prevention of cardiovascular events after myocardial infarction |
| Q35045801 | Angiotensin AT2 receptors: cardiovascular hope or hype? |
| Q42518248 | Angiotensin II AT(2) receptor inhibits smooth muscle cell migration via fibronectin cell production and binding |
| Q42477076 | Angiotensin II AT2 receptors are functionally coupled to protein tyrosine dephosphorylation in N1E-115 neuroblastoma cells |
| Q41073862 | Angiotensin II modulates cell growth-related events and synthesis of matrix proteins in renal interstitial fibroblasts |
| Q35884763 | Angiotensin II receptor expression and inhibition in the chronically hypoxic rat lung |
| Q44101267 | Angiotensin II type 1 receptor blockade after cardiac transplantation reduced the incidence and severity of transplant vasculopathy in an animal-based study |
| Q52954250 | Angiotensin II type 2 receptor gene polymorphism and cardiovascular phenotypes: the GLAECO and GLAOLD studies. |
| Q42987208 | Angiotensin II type 2 receptors mediate inhibition of mitogen-activated protein kinase cascade and functional activation of SHP-1 tyrosine phosphatase |
| Q71911932 | Angiotensin III and IV activation of the brain AT1 receptor subtype in cardiovascular function |
| Q34825028 | Angiotensin converting enzyme inhibitors and angiotensin II receptor blockers: evidence for and against the combination in the treatment of hypertension and proteinuria. |
| Q40599741 | Angiotensin receptors in cardiovascular diseases |
| Q46896298 | Angiotensin-(1-7) inhibits in vitro endothelial cell tube formation in human umbilical vein endothelial cells through the AT(1-7) receptor |
| Q41342574 | Angiotensinogen: molecular biology, biochemistry and physiology |
| Q40621879 | Antihypertensive drugs: issues beyond blood pressure control |
| Q71407503 | Characterisation of angiotensin II receptor mediated responses and inhibition of intimal hyperplasia in experimental vein grafts by the specific angiotensin II receptor inhibitor, L158,809 |
| Q37357707 | Chronic blockade of AT2-subtype receptors prevents the effect of angiotensin II on the rat vascular structure. |
| Q44230612 | Comparison of the antagonistic effects of different angiotensin II receptor blockers in human coronary arteries |
| Q43167619 | Deficiency or blockade of angiotensin II type 2 receptor delays tumorigenesis by inhibiting malignant cell proliferation and angiogenesis |
| Q43762867 | Do vascular compartments differ in the development of chronic rejection? AT(1) blocker candesartan versus Ace blocker enalapril in an experimental heart transplant model |
| Q35876449 | Dual blockade of the renin angiotensin system in diabetic and nondiabetic kidney disease |
| Q43518213 | Effect of the angiotensin II type 2-receptor gene (+1675 G/A) on left ventricular structure in humans |
| Q42993543 | Efficient transcription of the human angiotensin II type 2 receptor gene requires intronic sequence elements |
| Q47882488 | Evidence that angiotensin II, endothelins and nitric oxide regulate mitogen-activated protein kinase activity in rat aorta |
| Q34508369 | Extracellular matrix molecules, long-term potentiation, memory consolidation and the brain angiotensin system |
| Q33535928 | Heart allograft vascular disease: an obliterative vascular disease in transplanted hearts |
| Q46663979 | Immunolocalization of ACE2 and AT2 receptors in rabbit atherosclerotic plaques. |
| Q31877177 | Influence of angiotensin II type 1 receptor polymorphism on hypertension in patients with hypercholesterolemia |
| Q73286945 | Inhibitory effect of prostaglandin E1 on intimal thickening following photochemically induced endothelial injury in the rat femoral artery |
| Q57787242 | Interference With Endothelial PPAR (Peroxisome Proliferator-Activated Receptor)-γ Causes Accelerated Cerebral Vascular Dysfunction in Response to Endogenous Renin-Angiotensin System Activation |
| Q52937062 | Intronic ANG II type 2 receptor gene polymorphism 1675 G/A modulates receptor protein expression but not mRNA splicing. |
| Q78166862 | Local renin-angiotensin system and mitogen-activated protein kinase activation in rat aorta |
| Q73694937 | Lung angiotensin receptor binding characteristics during the development of monocrotaline-induced pulmonary hypertension |
| Q30306044 | Mechanism of action of angiotensin-receptor blocking agents |
| Q33743308 | Modulation and function of extrarenal angiotensin receptors |
| Q52170561 | Modulation of angiotensin II receptor expression during development and regression of hypoxic pulmonary hypertension. |
| Q48672854 | Modulation of angiotensin II type 2 receptor mRNA in rat hypothalamus and brainstem neuronal cultures by growth factors. |
| Q41084357 | Molecular biology of angiotensin receptors and their role in human cardiovascular disease |
| Q34942174 | Neural plasticity and the brain renin-angiotensin system |
| Q35750041 | Nitric oxide inhibits angiotensin II-induced migration of rat aortic smooth muscle cell. Role of cyclic-nucleotides and angiotensin1 receptors |
| Q30306043 | Novel actions of angiotensin II via its renal type-2 (AT(2)) receptor |
| Q34038063 | Optimal strategies for preventing progression of renal disease: should angiotensin converting enzyme inhibitors and angiotensin receptor blockers be used together? |
| Q43562117 | Perinatal dietary NaCl level: effect on angiotensin-induced thermal and dipsogenic responses in adult rats |
| Q60585299 | Regulated expression of pancreatic renin-angiotensin system in experimental pancreatitis |
| Q73250917 | Stimulation of angiotensin subtype 2 receptor reduces basal cGMP levels in the neointima of rat aorta after balloon injury |
| Q37218199 | Systemic and uteroplacental renin--angiotensin system in normal and pre-eclamptic pregnancies |
| Q33680652 | The AT2 receptor: fact, fancy and fantasy |
| Q38292393 | The Growth-dependent Expression of Angiotensin II Type 2 Receptor Is Regulated by Transcription Factors Interferon Regulatory Factor-1 and −2 |
| Q40478363 | The angiotensin AT2 receptor: searching for signal-transduction pathways and physiological function. |
| Q45190313 | The effect of hypothalamo-pituitary disconnection on the renin-angiotensin system in the late-gestation fetal sheep |
| Q34400269 | The renin-angiotensin system and vascular hypertrophy |
| Q34075171 | Therapeutic potential of ACE inhibitors for the treatment of hypertension in Type 2 diabetes |
| Q44289703 | Two good reasons for an angiotensin-II type 1 receptor blockade with losartan after cardiac transplantation: reduction of incidence and severity of transplant vasculopathy |
| Q35686201 | Vascular angiotensin II actions mediated by angiotensin II type 2 receptors |
| Q77965264 | Vascular mitogen-activated protein kinase activity is enhanced via angiotensin system in spontaneously hypertensive rats |
| Q42830674 | Vascular smooth-muscle cells contain AT1 angiotensin receptors coupled to phospholipase D activation |
Search more.